Inflammation initiated by oxidative stress in mitochondria is the cause of most cardiovascular disease.This extends over the entire spectrum of cardiovascul
Cardax Pharmaceuticals has developed an anti-inflammatory drug candidate, XanCor, which is a novel and highly bioavailable prodrug of the naturally occurrin
Transfusion of packed red blood cells (PRBC) has been shown to be an independent risk factor for the development of atrial fibrillation (AF) in a number of